<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 09 Sep 2026 07:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/OKYO+Pharma+to+Present+at+Ophthalmology+Futures+European+Forum+and+iNovation+Day+at+ESCRS+2026/27039035.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Company to engage with the global ophthalmology and investment community as it advances urcosimod through its global Phase 3 pivotal trial for neuropathic corneal pain&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;LONDON and NEW YORK, Sept.  09, 2026  (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=AByg62wjl1Sf7mEXsAKOWtUQcflQHonCpnhL6K5YXn3HuMDVmslfY7jX4Rpwhl_WIvKkSJfneG0W9ct8VNl8z8AUUEtpSGnPc1TndF3kOO1htVd6eyMwiXzokfK3IsOe&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;OKYO&lt;/a&gt;), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, today announced that it will present at Ophthalmology Futures Forum and in the 5th Annual ESCRS iNovation Day.&lt;/p&gt;  &lt;p&gt;Ophthalmology Futures European Forum on Thursday, September 10 in London is where clinical innovators, investors, and industry leaders</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/OKYO+Pharma+to+Present+at+Ophthalmology+Futures+European+Forum+and+iNovation+Day+at+ESCRS+2026/27039035.html</guid>
   <pubDate>Wed, 09 Sep 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/OKYO+Pharma+to+Present+at+Ophthalmology+Futures+European+Forum+and+iNovation+Day+at+ESCRS+2026/27039035.html</link>
   <description>&lt;p&gt;&lt;strong&gt;Company to engage with the global ophthalmology and investment community as it advances urcosimod through its global Phase 3 pivotal trial for neuropathic corneal pain&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;LONDON and NEW YORK, Sept.  09, 2026  (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=AByg62wjl1Sf7mEXsAKOWtUQcflQHonCpnhL6K5YXn3HuMDVmslfY7jX4Rpwhl_WIvKkSJfneG0W9ct8VNl8z8AUUEtpSGnPc1TndF3kOO1htVd6eyMwiXzokfK3IsOe&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;OKYO&lt;/a&gt;), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, today announced that it will present at Ophthalmology Futures Forum and in the 5th Annual ESCRS iNovation Day.&lt;/p&gt;  &lt;p&gt;Ophthalmology Futures European Forum on Thursday, September 10 in London is where clinical innovators, investors, and industry leaders</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/OKYO+Pharma+to+Present+at+Ophthalmology+Futures+European+Forum+and+iNovation+Day+at+ESCRS+2026/27039035.html</guid>
   <pubDate>Wed, 09 Sep 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/OKYO+Pharma+to+Participate+in+a+Fireside+Chat+at+the+Cantor+Global+Healthcare+Conference/27032925.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;LONDON and NEW YORK, Sept.  08, 2026  (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=XSCJ14syqUttLPpcvfAdpTcoYAenQTO555hrbuALepB-LS_posNOJUcX2E4OtZFkZKilm2C_LiKU6hDcDGlZbPFqVnpfJvMmtMZ4O5lhT579dU7srjlUYYRFnB-ymS5M&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;OKYO&lt;/a&gt;), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, today announced participation at the Cantor Global Healthcare Conference being held September 9-11, 2026.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Details of the event are as follows: &lt;/strong&gt;&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Presenters:&lt;/strong&gt; Flavio Mantelli, MD, PhD, Chief Medical Officer, Gary Jacob, PhD, Chief Development Officer&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Date/Time: &lt;/strong&gt;Thursday, September 10 at 8:35 AM ET&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Moderator:&lt;/strong&gt; Eric Fitzgerald, Cantor Fitzgerald&lt;/p&gt;  &lt;p&gt;The Company will be available for one-on-one</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/OKYO+Pharma+to+Participate+in+a+Fireside+Chat+at+the+Cantor+Global+Healthcare+Conference/27032925.html</guid>
   <pubDate>Tue, 08 Sep 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Globe+Newswire/OKYO+Pharma+to+Participate+in+a+Fireside+Chat+at+the+Cantor+Global+Healthcare+Conference/27032925.html</link>
   <description>&lt;p align=&quot;left&quot;&gt;LONDON and NEW YORK, Sept.  08, 2026  (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: &lt;a href=&quot;https://www.globenewswire.com/Tracker?data=XSCJ14syqUttLPpcvfAdpTcoYAenQTO555hrbuALepB-LS_posNOJUcX2E4OtZFkZKilm2C_LiKU6hDcDGlZbPFqVnpfJvMmtMZ4O5lhT579dU7srjlUYYRFnB-ymS5M&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;OKYO&lt;/a&gt;), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, today announced participation at the Cantor Global Healthcare Conference being held September 9-11, 2026.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Details of the event are as follows: &lt;/strong&gt;&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Presenters:&lt;/strong&gt; Flavio Mantelli, MD, PhD, Chief Medical Officer, Gary Jacob, PhD, Chief Development Officer&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Date/Time: &lt;/strong&gt;Thursday, September 10 at 8:35 AM ET&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Moderator:&lt;/strong&gt; Eric Fitzgerald, Cantor Fitzgerald&lt;/p&gt;  &lt;p&gt;The Company will be available for one-on-one</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/OKYO+Pharma+to+Participate+in+a+Fireside+Chat+at+the+Cantor+Global+Healthcare+Conference/27032925.html</guid>
   <pubDate>Tue, 08 Sep 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  20-F/A     OKYO Pharma Ltd           For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++20-FA+++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+31/26891540.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891540.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++20-FA+++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+31/26891540.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  20-F/A     OKYO Pharma Ltd           For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++20-FA+++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+31/26891540.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891540.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++20-FA+++++OKYO+Pharma+Ltd+++++++++++For%3A+Mar+31/26891540.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 20  Filed by: CERRONE GABRIELE M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+20++Filed+by%3A+CERRONE+GABRIELE+M/26891240.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891240.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+20++Filed+by%3A+CERRONE+GABRIELE+M/26891240.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 20  Filed by: CERRONE GABRIELE M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+20++Filed+by%3A+CERRONE+GABRIELE+M/26891240.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891240.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+20++Filed+by%3A+CERRONE+GABRIELE+M/26891240.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 20  Filed by: CERRONE GABRIELE M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+20++Filed+by%3A+CERRONE+GABRIELE+M/26891240.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891240.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+20++Filed+by%3A+CERRONE+GABRIELE+M/26891240.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 27  Filed by: Patil Rajkumar V.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+27++Filed+by%3A+Patil+Rajkumar+V./26891241.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891241.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+27++Filed+by%3A+Patil+Rajkumar+V./26891241.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 27  Filed by: Patil Rajkumar V.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+27++Filed+by%3A+Patil+Rajkumar+V./26891241.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891241.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+27++Filed+by%3A+Patil+Rajkumar+V./26891241.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 27  Filed by: Patil Rajkumar V.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+27++Filed+by%3A+Patil+Rajkumar+V./26891241.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891241.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+27++Filed+by%3A+Patil+Rajkumar+V./26891241.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 21  Filed by: Mantelli Flavio</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+Mantelli+Flavio/26891244.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891244.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+Mantelli+Flavio/26891244.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 21  Filed by: Mantelli Flavio</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+Mantelli+Flavio/26891244.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891244.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+Mantelli+Flavio/26891244.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 21  Filed by: Mantelli Flavio</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+Mantelli+Flavio/26891244.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891244.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+Mantelli+Flavio/26891244.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 21  Filed by: JACOB GARY S</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+JACOB+GARY+S/26891247.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891247.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+JACOB+GARY+S/26891247.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 21  Filed by: JACOB GARY S</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+JACOB+GARY+S/26891247.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891247.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+JACOB+GARY+S/26891247.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 21  Filed by: JACOB GARY S</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+JACOB+GARY+S/26891247.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891247.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+JACOB+GARY+S/26891247.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 21  Filed by: CERRONE GABRIELE M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+CERRONE+GABRIELE+M/26891251.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891251.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+CERRONE+GABRIELE+M/26891251.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 21  Filed by: CERRONE GABRIELE M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+CERRONE+GABRIELE+M/26891251.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891251.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+CERRONE+GABRIELE+M/26891251.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 21  Filed by: CERRONE GABRIELE M</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+CERRONE+GABRIELE+M/26891251.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891251.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+CERRONE+GABRIELE+M/26891251.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 22  Filed by: Dempsey Robert John</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+22++Filed+by%3A+Dempsey+Robert+John/26891258.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891258.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+22++Filed+by%3A+Dempsey+Robert+John/26891258.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 22  Filed by: Dempsey Robert John</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+22++Filed+by%3A+Dempsey+Robert+John/26891258.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891258.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+22++Filed+by%3A+Dempsey+Robert+John/26891258.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 22  Filed by: Dempsey Robert John</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+22++Filed+by%3A+Dempsey+Robert+John/26891258.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891258.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+22++Filed+by%3A+Dempsey+Robert+John/26891258.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
  <item>
   <title>Form  4/A        OKYO Pharma Ltd           For: Jul 21  Filed by: BRANCACCIO JOHN P</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+BRANCACCIO+JOHN+P/26891259.html</link>
   <description>si-local-file:///var/storage/secattach/20260807/26891259.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4A++++++++OKYO+Pharma+Ltd+++++++++++For%3A+Jul+21++Filed+by%3A+BRANCACCIO+JOHN+P/26891259.html</guid>
   <pubDate>Fri, 07 Aug 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.38528770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">OKYO</category>
   	  </item>
 </channel>
</rss>
